We are live on
!
Find out more
CIS
Capital International Sarl Portfolio holdings
AUM
$6.11B
1-Year Est. Return
32.29%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.46B
Cap. Flow
% of AUM
102.68%
Top 10 Holdings %
Top 10 Hldgs %
33.38%
Holding
137
New
137
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$77.4M |
| 2 |
Banco Bradesco
BBD
|
+$50.8M |
| 3 |
CIE
Cobalt International Energy, Inc
CIE
|
+$49.8M |
| 4 |
Arcos Dorados Holdings
ARCO
|
+$48.8M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$44.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.4% |
| 2 | Healthcare | 13.12% |
| 3 | Energy | 11.73% |
| 4 | Communication Services | 10% |
| 5 | Consumer Discretionary | 9.6% |
Similar funds
HCM
DTC
AA
AWA
ACM
JWBC
GA
EMPI
Capital International Sarl's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital International Sarl, which disclosed 137 positions worth $1.42B. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Gilead Sciences: 1,485,080 shares worth $76.1M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Healthcare and Energy.
- Capital International Sarl's largest Q2 2013 buy was Gilead Sciences: 1,485,080 shares worth $76.1M.
- Capital International Sarl's ten largest holdings make up 33% of its $1.42B portfolio in Q2 2013.
- Capital International Sarl disclosed 137 positions in Q2 2013, its first 13F filing on record.
Based on Capital International Sarl's 13F filing for Q2 2013, filed 14 Aug 2013.